Wells Fargo & Company Homology Medicines, Inc. Call Options Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
Call Options
1 transactions
Others Institutions Holding FIXX
# of Institutions
5Shares Held
66.2KCall Options Held
0Put Options Held
0-
Oup Management Co., LLC64KShares$00.17% of portfolio
-
Endurance Wealth Management, Inc.2KShares$00.0% of portfolio
-
Sargent Bickham Lagudis LLC200Shares$00.0% of portfolio
-
Coppell Advisory Solutions LLC Coppell, TX11Shares$00.0% of portfolio
-
Sachetta, LLC Lynnfield, MA1Shares$00.0% of portfolio
About Homology Medicines, Inc.
- Ticker FIXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,402,000
- Description
- Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...